Europe/Asia USA
Bachem AG Bachem Americas, Inc.
Hauptstrasse 144 3132 Kashiwa Street
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA
Tel +41 61 935 2323 Tel +1 888 422 2436
Fax +41 61 935 2325 +1 888 4BACHEM
E-mail sales.ch@bachem.com +1 310 539 4171
  Fax +1 310 539 9428
  E-mail sales.us@bachem.com

CORPORATE GOVERNANCE

Honorary Chairman

 

Peter Grogg (1942) Dr. h.c., Honorary Chairman, Swiss
Peter Groggsince 1971
Honorary Chairman
Peter Grogg founded Bachem AG in 1971 and was the CEO until 2002 and Chairman of the Board of Bachem Holding AG until 2012. He is Chairman of the Board of Ingro Finanz AG. He is a member of the Board of Directors of Polyphor AG, and Sunstar Holding AG.

 
 

Board of Directors

 

Kuno Sommer (1956) 1, Ph.D. in Business Administration, Chairman, Swiss
Kuno Sommer since 2012, elected until 2017
Chairman
Dr. Kuno Sommer, Ph.D. University of Basel, worked for Roche from 1986 to 1999 in various functions, including four years  in the USA. Kuno Sommer was ultimately a member of the Executive Committee of Roche, responsible for the Flavours and Fragrances division, today Givaudan. From 2000 to 2006 he was CEO of Berna Biotech. Kuno Sommer is Chairman of the Board of Kenta Biotech AG and member of the Board of Polyphor AG.
Nicole-Grogg-HoetzerNicole Grogg Hötzer (1973), Graduate Biologist, Vice-Chairwoman, Swiss
Nicole Grogg Hötzersince 2011, elected until 2017
Member
Nicole Grogg Hötzer graduated in Biology at Basel University in 1999. Afterwards, she worked in various positions in the field of regulatory affairs. In 2002 Nicole Grogg Hötzer began her postgraduate studies in Business Administration at the University of Applied Sciences Basel which she completed successfully in 2004. Nicole Grogg Hötzer is Vice Chairwoman of the Board of Directors of Ingro Finanz AG and member of the Board of Directors of MFC Beteiligungs AG.
Jürgen Brokatzky-Geiger (1952) 1, Ph.D. in chemistry, Member, German
Jürgen Brokatzky-since 2009, elected until 2017
Geiger
MemberDr. Jürgen Brokatzky-Geiger graduated with a Ph.D. in chemistry from the University of Freiburg, Germany, in 1982. He joined Ciba-Geigy Ltd. in 1983 as a Laboratory Head in the Pharmaceuticals Division. After a job rotation in the United States, he held positions of increasing responsibility in Research and Development (R&D) including Group Leader of Process R&D, Head of Process R&D, and Head of Process Development and Pilot Plant Operations. During the merger of Ciba-Geigy and Sandoz in 1996, Dr. Jürgen Brokatzky-Geiger was appointed Integration Officer of Technical Operations. He later became the Head of Chemical and Analytical Development and served as the Global Head of Technical R&D from 1999 to August 2003. Dr. Jürgen Brokatzky-Geiger was appointed to his present position as Head of Human Resources on September 1, 2003. He has been a member of the Executive Committee of Novartis since January 1, 2005.
Thomas Burckhardt (1950) Dr. iur., LL.M., Member, Secretary of the Board, Swiss
Thomas Burckhardtsince 1997, elected until 2017
Member, Secretary of the Board
Thomas Burckhardt studied at the universities of Basel, Geneva and Munich and was awarded his doctorate in 1978 in Basel. Since 1975, he is licensed attorney and in 1979, he received a Master of Law (LL.M.) at Harvard Law School (Cambridge, Massachusetts, US). Since 1980, he is practicing as lawyer in Zurich and Basel and since 1987, he is an associate at Simonius Pfrommer & Partner. Thomas Burckhardt further is Honorary Consul-General of the Kingdom of Thailand in Basel. Other important Board memberships: Viking River Cruises AG, MFC Beteiligungs AG and Stiftung FOCUS Basel.
Helma Wennemers (1969) Prof. Dr., Member, German
Helma Wennemerssince 2014, elected until 2017
Member
Helma Wennemers is a German national and has been Professor at the Laboratory of Organic Chemistry at ETH Zurich since 2011. She was born in Offenbach am Main in 1969 and graduated with a diploma degree in chemistry from Johann-Wolfgang-Goethe University in Frankfurt in 1993. Three years later she earned a doctorate degree from Columbia University, New York. She then pursued post-doctoral studies at Nagoya University before accepting the "Bachem-Stiftungs-Assistenzprofessur" at the University of Basel in 1999, where she became Associate Professor in 2003. Helma Wennemers research has been recognized by several awards including the "Leonidas Zervas Award" (2010) and the "Goering Visiting Professorship of the University of Wisconsin, Madison" (2004). She has also been awarded with numerous honorary lectureships such as the "David Ginsburg Lectureship" at the Technion in Haifa (2010) and was named a "Fellow of the Royal Society of Chemistry" (2013).
Rolf Nyfeler (1950) 1, Dr. phil. II, Member, Swiss
Rolf Nyfelersince 2012, elected until 2017
Member
Rolf Nyfeler studied chemistry at Basel University and was awarded his doctorate in 1979. Afterwards he deepened his knowledge with postdoc stays at the Max-Planck-Institute in Martinsried and at the University of California in San Diego. Rolf Nyfeler joined Bachem in 1982. For many years he was responsible for Research and Development in Bubendorf. Then, after spending some time as Head of Production in the subsidiary in California, he became COO of the Parent company in 1998. From 2002 to 2012, he was CEO of the Bachem Group and Chairman of the Corporate Executive Committee.
1 Member of the Compensation Committee



Corporate Executive Committee

 

Thomas FrühThomas Früh (1957) Dr. chem. ETH, CEO, Swiss
Thomas Früh since 2012
CEO
Thomas Früh joined Bachem in 1997. He was first COO of the Bachem Group Company in Pennsylvania and became COO of Bachem AG in 2001. Since April 1, 2012 he is CEO of Bachem Holding AG and Chairman of the Corporate Executive Committee. He completed his education as a chemist at the Swiss Federal Institute of Technology in Zürich (ETH) and then was research fellow at Harvard University in Cambridge. Before he joined Bachem, he held various research and development positions at Ciba-Geigy and Novartis. Thomas Früh is member of the Board of Directors of Dottikon ES Holding AG.

José de ChastonayJosé de Chastonay (1954) Dr. Phil. Nat. & MBA, CMO, Swiss/American
José de Chastonaysince 2012
CMO
José de Chastonay joined Bachem AG in 1991 as International Marketing Manager. As of 1992, he relocated to the USA, first as President and COO of Bachem Bioscience, Inc. and subsequently of Bachem, Inc. and ultimately as President of Bachem Americas. In 2007, he left Bachem to become CEO of Irvine Scientific Inc. and Managing Director of Wombat Capital Ltd. in Los Angeles, before rejoining Bachem as Chief Marketing Officer in 2012. José de Chastonay started his industrial career with Ares Serono as Assistant Director of Biotechnology and joined Roche Diagnostica as International Product Lines Manager several years later. He served on the Board of Directors of Viroblock SA as well as on the Strategic Advisory Board of Rapid Pharmaceuticals and serves as Treasurer of the European University Foundation. José de Chastonay earned his Ph.D. in medical microbiology from the University of Bern and his MBA from the European University in Montreux.

Alex Fässler (1955) Dr. Sc. Nat., COO, Swiss/American
Alex Fässlersince 2017
COO
Alex Fässler joined Bachem AG in 1998, before he relocated to the USA, where he served as Head of Production, Site Manager, and ultimately as the Regional COO for the Americas. In 2013 he returned to Switzerland to become COO of the European Operations. He was appointed COO of the Bachem Group and member of the Corporate Executive Committee effective April 1. 2017. Alex Fässler started his industrial career at Ciba-Geigy, later Novartis, where he held various positions in preclinical Research. He completed his education at the Swiss Institute of Technology in Zurich (ETH) with a Ph.D. in organic chemistry, followed by a fellowship at the University of California, Berkeley.

 

Guenther LoidlGuenther Loidl (1970) Dr. rer. nat., CTO, German
CTOsince 2015
Guenther Loidl joined Bachem in 2000. He held several functions in Research and Development (R&D) and Active Pharmaceutical Ingredient Manufacturing and became Vice President R&D in 2012. Since 2015, he is CTO of the Bachem Group and a member of the Corporate Executive Committee. He studied chemistry in Regensburg (Germany) and Leeds (UK) and obtained his doctorate under the supervision of Prof. Dr. Luis Moroder at the Max Planck Institute of Biochemistry in Martinsried (Germany).

 
 

Stephan Schindler (1964) business economist HWV, EMBA, CFO, Swiss
Stephan Schindlersince 2009
CFO
Stephan Schindler joined Bachem Holding AG as Chief Financial Officer (CFO) and Member of the Corporate Executive Committee in 2009. In 1991, he assumed a first management position in informatics as Head of Information Center at Patria Insurances in Basel. In parallel, he persistently pursued his extra occupational studies in business economics, finance and control. After his graduation, he joined the Corporate Finance Department at F. Hoffmann- La Roche Ltd in Basel. 1995 to 2001, he assumed various positions, e.g. Head of Credit Management. With the unbundling of the division in 2001, he took over the accounting & reporting department at Roche Vitamins Ltd. Until 2009, he was Head Finance & Control Switzerland at DSM Nutritional Products Ltd, Kaiseraugst. In addition, Stephan Schindler holds a degree of International Executive MBA Zurich/Boston.